A Study of IMAB362 in Japanese Subjects with Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Trial Identifier:	8951-CL-0104
Sponsor:	Astellas Pharma Inc.
Start Date:	June 2018
Primary Completion Date:	June 2020
Study Completion Date:	June 2020
Condition:	Gastric Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan, Chiba	Kashiwa, Chiba, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.